Page last updated: 2024-10-28

ha 1004 and Bladder Cancer

ha 1004 has been researched along with Bladder Cancer in 3 studies

N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koike, K1
Uchiumi, T1
Ohga, T1
Toh, S1
Wada, M1
Kohno, K1
Kuwano, M1
Zhang, Y1
Mahendran, R1
Yap, LL1
Esuvaranathan, K1
Khoo, HE1
Hubbell, HR1
Boyer, JE1
Roane, P1
Burch, RM1

Other Studies

3 other studies available for ha 1004 and Bladder Cancer

ArticleYear
Nuclear translocation of the Y-box binding protein by ultraviolet irradiation.
    FEBS letters, 1997, Nov-17, Volume: 417, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; CCAAT-Enhancer-Binding Proteins; Cell Nucleu

1997
The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells.
    Biochemical pharmacology, 2002, Jan-15, Volume: 63, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenine; Antibodies; BCG Vaccine; Colforsin; Cyclic A

2002
Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Feb-01, Volume: 88, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenylyl Cyclases; Astrocytoma; Base Composition; Car

1991